Status: Recruiting
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Participants needed: 60
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Fibralign CorporationUpdated: Mar 11, 2025Locations: 1
Eligibility criteria
Ages 18 to 75 years (inclusive) [+14]
Edema arising from increased capillary filtration will be excluded (venous incom... [+20]